Sentrex Health Solutions Expands Services with Acquisition of PerCuro Clinical Research
Sentrex Health Solutions announced the acquisition of PerCuro Clinical Research, a full-service specialty pharmacy and healthcare services provider based in Victoria, Canada. PerCuro Clinical Research provides infusion services, clinical research and advanced nursing care. The company treats patients across several therapeutic areas, including inflammatory bowel disease, liver disease, neurology, dermatology and rare diseases. Established in 2003, PerCuro partners with healthcare providers on Vancouver Island, bringing healthcare services closer to physicians and patients. Sentrex Health Solutions Inc. is a Canadian healthcare company based in Markham, Ontario. The company... Read More »
Clarest Health Acquires Remedi SeniorCare
Clarest Health, a leading personalized medication management provider, announced that it has acquired Remedi SeniorCare, giving Clarest the size and scale to lead the post-acute care market. The U.S. market for pharmacy care for the post-acute patient population is $5.7 billion, and the U.S. Rx fill market for medically complex patients is $115 billion, according to interviews, research and analysis from L.E.K. Financial terms of the deal were not disclosed. Headquartered in Towson, Maryland, Remedi SeniorCare is a long-term and post-acute care pharmacy services provider. Renowned for its long-term care pharmacy services and proprietary medication management system PAXIT® and its... Read More »
Hildred Capital Management Acquires AleraCare
New York-based private equity firm Hildred Capital Management announced on May 2 that it entered into an agreement to acquire AleraCare for an undisclosed price. AleraCare is a provider of infusion and specialty pharmacy services. Founded in 2019, AleraCare’s core lines of business includes infusions at ambulatory infusion centers, home infusion therapy, specialty pharmacy and compounding pharmacy. It has more than 35 locations in the western United States. Hildred Capital Management pursues growth equity investments in lower middle market healthcare companies with leading products, technologies and services. AleraCare will use the capital provided by Hildred to further enhance its... Read More »
A Resilient Industry: M&A Trends in Specialty Pharmacy
Significant changes have swept the specialty pharmacy market over the past several years. It was once a niche in the pharmacy industry but has grown significantly in market size. According to a report by Axtria, specialty drug spending is growing and constituted about 46% ($222.9 billion) of all prescription drugs in 2019, compared with 34.9% ($132 billion) in 2014. These numbers make sense with the tailwinds that pushed the industry, such as an aging population in the U.S. creating a greater need for medications that treat chronic and complex diseases. Most of the changes in the market have come from M&A activity. Consolidation has swept the industry, with a few players controlling... Read More »
Elevance Health Acquires Specialty Pharmacy BioPlus
Elevance Health acquired Altamonte Springs, Florida-based specialty pharmacy BioPlus from CarepathRx. Terms of the deal were not disclosed. BioPlus provides services for patients living with complex and chronic conditions, such as cancer, multiple sclerosis, Hepatitis C, autoimmune diseases and rheumatology. Indianapolis-based Elevance Health connects consumers, families and communities to the care, support and resources they need. Its companies serve more than 119 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical and complex care solutions. According to the LevinPro HC database, this was the 23rd specialty pharmacy transaction of 2022. This compares... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
